Tissue Regenix Group Overview
- Year Founded
-
2006
- Status
-
Private
- Employees
-
62
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
13
- Investments
-
3
Tissue Regenix Group General Information
Description
Tissue Regenix Group PLC is an international medical technology company focused on the development, processing, and commercialisation of regenerative medical products through its two proprietary platform technologies, dCELL and BioRinse. The Group's products include Musculoskeletal, Dermis, Soft Tissue - OrthoPure XT and Birth Tissue. The Group's principal operational facility is located in San Antonio, Texas, where the majority of dCELL and BioRinse product processing and manufacturing activities are undertaken, and it also operates a facility in Leeds, United Kingdom, focused on the processing of porcine soft tissue products. The Company operates in the US and the Rest of World, with maximum revenue from the US.
Contact Information
Website
www.tissueregenix.comCorporate Office
- 1808 Universal City Boulevard
- Universal City, TX 78148
- United States
Corporate Office
- 1808 Universal City Boulevard
- Universal City, TX 78148
- United States
Tissue Regenix Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Tissue Regenix Group Comparisons
Industry
Financing
Details
Tissue Regenix Group Competitors (9)
One of Tissue Regenix Group’s 9 competitors is Encoll, a Corporation company based in Fremont, CA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Encoll | Corporation | Fremont, CA | ||||
| Orthofix Medical | Formerly PE-Backed | Lewisville, TX | ||||
| Organogenesis Holdings | Pending Transaction (M&A) | Canton, MA | ||||
| TRACON Pharmaceuticals | Formerly VC-backed | San Diego, CA | ||||
| Bone Biologics | Corporation | Burlington, MA |
Tissue Regenix Group Patents
Tissue Regenix Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2021231961-A1 | A method for producing a decellularized tissue scaffold | Pending | 05-Mar-2020 | ||
| EP-4114476-A1 | A method for producing a decellularized tissue scaffold | Active | 05-Mar-2020 | ||
| EP-4114476-B1 | A method for producing a decellularized tissue scaffold | Active | 05-Mar-2020 | ||
| EP-4114476-C0 | A method for producing a decellularized tissue scaffold | Active | 05-Mar-2020 | ||
| EP-4582111-A2 | A method for producing a decellularized tissue scaffold | Pending | 05-Mar-2020 | A61L27/3633 |
Tissue Regenix Group Signals
Tissue Regenix Group Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Tissue Regenix Group Investments & Acquisitions (3)
Tissue Regenix Group’s most recent deal was a Merger/Acquisition with CellRight Technologies for . The deal was made on 21-Jul-2017.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| CellRight Technologies | 21-Jul-2017 | Merger/Acquisition | Biotechnology | ||
| GBM-V gemeinnützige | 27-Jan-2016 | Joint Venture | Hospitals/Inpatient Services | ||
| Oxeco (London) | 30-Jun-2010 | Merger/Acquisition | Other Healthcare Services |
Tissue Regenix Group FAQs
-
When was Tissue Regenix Group founded?
Tissue Regenix Group was founded in 2006.
-
Where is Tissue Regenix Group headquartered?
Tissue Regenix Group is headquartered in Universal City, TX.
-
What is the size of Tissue Regenix Group?
Tissue Regenix Group has 62 total employees.
-
What industry is Tissue Regenix Group in?
Tissue Regenix Group’s primary industry is Biotechnology.
-
Is Tissue Regenix Group a private or public company?
Tissue Regenix Group is a Private company.
-
What is the current valuation of Tissue Regenix Group?
The current valuation of Tissue Regenix Group is .
-
What is Tissue Regenix Group’s current revenue?
The current revenue for Tissue Regenix Group is .
-
How much funding has Tissue Regenix Group raised over time?
Tissue Regenix Group has raised $145M.
-
Who are Tissue Regenix Group’s investors?
Harwood Private Equity has invested in Tissue Regenix Group.
-
Who are Tissue Regenix Group’s competitors?
Encoll, Orthofix Medical, Organogenesis Holdings, TRACON Pharmaceuticals, and Bone Biologics are some of the 9 competitors of Tissue Regenix Group.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process